These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 38091082

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Neuroendocrine neoplasms of the head and neck].
    Konukiewitz B, Agaimy A, Weichert W, Klöppel G.
    Pathologe; 2018 Feb; 39(1):27-34. PubMed ID: 29313083
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Well-differentiated pancreatic neuroendocrine tumours (PanNETs) and poorly differentiated pancreatic neuroendocrine carcinomas (PanNECs): concepts, issues and a practical diagnostic approach to high-grade (G3) cases.
    Singhi AD, Klimstra DS.
    Histopathology; 2018 Jan; 72(1):168-177. PubMed ID: 29239037
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
    Jiang Y, Xie J, Wang B, Mu Y, Liu P.
    Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
    [Abstract] [Full Text] [Related]

  • 9. Mesenchymal/non-epithelial mimickers of neuroendocrine neoplasms with a focus on fusion gene-associated and SWI/SNF-deficient tumors.
    Kasajima A, Konukiewitz B, Schlitter AM, Weichert W, Bräsen JH, Agaimy A, Klöppel G.
    Virchows Arch; 2021 Dec; 479(6):1209-1219. PubMed ID: 34350470
    [Abstract] [Full Text] [Related]

  • 10. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.
    Rindi G, Mete O, Uccella S, Basturk O, La Rosa S, Brosens LAA, Ezzat S, de Herder WW, Klimstra DS, Papotti M, Asa SL.
    Endocr Pathol; 2022 Mar; 33(1):115-154. PubMed ID: 35294740
    [Abstract] [Full Text] [Related]

  • 11. PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma.
    Sangoi AR, Ohgami RS, Pai RK, Beck AH, McKenney JK, Pai RK.
    Mod Pathol; 2011 Mar; 24(3):412-24. PubMed ID: 20890270
    [Abstract] [Full Text] [Related]

  • 12. Synaptophysin and chromogranin A expression analysis in human tumors.
    Uhlig R, Dum D, Gorbokon N, Menz A, Büscheck F, Luebke AM, Hube-Magg C, Hinsch A, Höflmayer D, Fraune C, Möller K, Bernreuther C, Lebok P, Weidemann S, Lennartz M, Jacobsen F, Clauditz TS, Sauter G, Wilczak W, Steurer S, Burandt E, Krech R, Krech T, Marx AH, Simon R, Minner S.
    Mol Cell Endocrinol; 2022 Sep 15; 555():111726. PubMed ID: 35921917
    [Abstract] [Full Text] [Related]

  • 13. [Practical application of immunohistochemistry in pancreatic neuroendocrine neoplasms : Tips and pitfalls].
    Bräutigam K, Chouchane A, Konukiewitz B, Perren A.
    Pathologie (Heidelb); 2024 Feb 15; 45(1):35-41. PubMed ID: 38175232
    [Abstract] [Full Text] [Related]

  • 14. P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms.
    Nielsen K, Binderup T, Langer SW, Kjaer A, Knigge P, Grøndahl V, Melchior L, Federspiel B, Knigge U.
    BMC Cancer; 2020 Jan 10; 20(1):27. PubMed ID: 31924180
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pancreatic neuroendocrine tumor and solid-pseudopapillary neoplasm: Key immunohistochemical profiles for differential diagnosis.
    Ohara Y, Oda T, Hashimoto S, Akashi Y, Miyamoto R, Enomoto T, Satomi K, Morishita Y, Ohkohchi N.
    World J Gastroenterol; 2016 Oct 14; 22(38):8596-8604. PubMed ID: 27784972
    [Abstract] [Full Text] [Related]

  • 18. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.
    Kasprzak A, Zabel M, Biczysko W.
    Pol J Pathol; 2007 Oct 14; 58(1):23-33. PubMed ID: 17585539
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.